Drug
Pirfenidone (PFD)
Pirfenidone (PFD) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
1
25%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
Trials by Status
completed375%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects
NCT07456800
completedphase_1
Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis
NCT06871904
not_yet_recruitingphase_3
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
NCT07284602
completedphase_2
Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate
NCT03221257
Clinical Trials (4)
Showing 4 of 4 trials
NCT07456800Phase 1
PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects
NCT06871904Phase 1
Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis
NCT07284602Phase 3
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
NCT03221257Phase 2
Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4